Joyce Tsai
Vice President of Clinical Sciences at Compass Pathways
Key Impact
She is a clinical-science leader on the Compass Pathways psilocybin program, helping drive some of the most visible contemporary trials of psilocybin for treatment-resistant depression.
Background & Research
Joyce Tsai, PhD, is a clinical sciences executive at Compass Pathways, where she has been publicly identified as Vice President of Clinical Sciences. She appears as an author on multiple Compass psilocybin depression papers, including work on treatment-resistant depression, SSRI coadministration, antidepressant discontinuation, and the subjective psychedelic experience.
Collaboration Network
26 collaborators· click a node to visit their profile
Full network →